Skip to main content
SpringerLink
Log in

Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system

  • Review Article
  • Section I: CD44 Expression in the Nervous System
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Flanagan BF, Dalchau R, Allen AK, Daar AS, Fabre JW: Chemical composition and tissue distribution of the human CDw44 glycoprotein. Immunology 67:167–175, 1989

    Google Scholar 

  2. Picker LJ, De los Toyos J, Telen MJ, Haynes BF, Butcher EC: Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J Immunol 142: 2046–2051, 1989

    Google Scholar 

  3. Herrlich P, Rudy W, Hofmann M, Arch R, Zoller M, Zawadzki V, Tolg C, Hekele A, Koopman G, Pals S, Heider K-H, Sleeman J, Ponta H: CD44 and splice variants of CD44 in normal differentiation and tumour progression. In: Hemler M, Mihich E (eds) Cell Adhesion Molecules. Plenum Press, New York 265–288, 1993

    Google Scholar 

  4. Haegel H, Tolg C, Hofmann M, Ceredig R: Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding. J Cell Biol 122: 1067–1077, 1993

    Google Scholar 

  5. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303–1313, 1990

    Google Scholar 

  6. Lesley J, Schulte R, Hyman R: Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp Cell Res 187: 224–233, 1990

    Google Scholar 

  7. Miyake K, Underhill CB, Lesley J, Kincade PW: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172: 69–75, 1990

    Google Scholar 

  8. Jalkanen S, Jalkanen M: Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116: 817–825, 1992

    Google Scholar 

  9. Goldstein LA, Zhou DF, Picker LJ, Minty CN, Bargatze RF, Ding JF, Butcher EC: A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56: 1063–1072, 1989

    Google Scholar 

  10. Carter WG, Wayner EA: Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263: 4193–4201, 1988

    Google Scholar 

  11. Merzak A, Koocheckpour S, Pilkington GJ: CD44 mediates human glioma cell adhesion and invasionin vitro. Cancer Res 54: 3988–3992, 1994

    Google Scholar 

  12. Stamenkovic I, Aruffo A, Amiot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronatebearing cells. EMBO J 10: 343–348, 1991

    Google Scholar 

  13. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160–12164, 1992

    Google Scholar 

  14. Sy MS, Guo YJ, Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growthin vivo. J Exp Med 174: 859–866, 1991

    Google Scholar 

  15. Sherman L, Sleeman J, Herrlich P, Ponta H: Hyaluronate receptors — key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 6: 726–733, 1994

    Google Scholar 

  16. Lokeshwar VB, Fregien N, Bourguignon LY: Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronate acid-mediated adhesion function. J Cell Biol 126: 1099–1109, 1994

    Google Scholar 

  17. Isacke CM: The role of the cytoplasmic domain in regulating CD44 function. J Cell Sci 1994

  18. Girgrah N, Ackerley CA, Moscarello MA: Localization of CD44 (P80) on the external surface of a human astrocytoma cell. Neuroreport 2: 441–444, 1991

    Google Scholar 

  19. Vogel H, Butcher EC, Picker LJ: H-CAM expression in the human nervous system: evidence for a role in diverse glial interactions. J Neurocytol 21: 363–373, 1992

    Google Scholar 

  20. Kuppner MC, Van Meir EG, Gauthier T, Hamou M-F, de Tribolet N: Differential expression of the CD44 molecule in human brain tumours. Int J Cancer 50: 572–577, 1992

    Google Scholar 

  21. Girgrah N, Letarte M, Becker LE, Cruz TF, Theriault E, Moscarello MA: Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J Neuropathol Exp Neurol 50: 779–792, 1991

    Google Scholar 

  22. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180: 53–66, 1994

    Google Scholar 

  23. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13–24, 1991

    Google Scholar 

  24. Russell DS, Rubinstein LJ: Pathology of tumours of the nervous system. 5th. London. Edward Arnold. 1989

    Google Scholar 

  25. Moretto G, Xu RY, Kim SU: CD44 expression in human astrocytes and oligodendrocytes in culture. J Neuropathol Exp Neurol 52: 419–423, 1993

    Google Scholar 

  26. Underhill C: The interaction of hyaluronate with the cell surface: the hyaluronate receptor and the core protein. In: Evered D, Whelan J (eds) The Biology of Hyaluronan. John Wiley & Sons, Chichester, 1989

    Google Scholar 

  27. Delpech B, Delpech A, Bruckner G, Girard N, Maingonnat C: Hyaluronan and haluronectin in the nervous system. In: Evered D, Whelen J (eds) The Biology of Hyaluronan. John Wiley & Sons, Chichester 208–232, 1989

    Google Scholar 

  28. Rutka JT, Apodaca G, Stern R, Rosenblum M: The extracellular matrix of the central and peripheral nervous systems: structure and function. [Review]. J Neurosurg 69: 155–170, 1988

    Google Scholar 

  29. Asher R, Bignami A: Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 203: 80–90, 1992

    Google Scholar 

  30. Asher R, Bignami A: Localization of hyaluronate in primary glial cell cultures derived from newborn rat brain. Exp Cell Res 195: 401–411, 1991

    Google Scholar 

  31. Asher R, Perides G, Vanderhaeghen JJ, Bignami A: Extracellular matrix of central nervous system white matter: demonstration of an hyaluronate-protein complex. J Neurosci Res 28: 410–421, 1991

    Google Scholar 

  32. Zulch H: Histological typing of tumours of the central nervous system. Geneva. World Health Organization. 1979

    Google Scholar 

  33. Kuppner MC, Hamou M-F, de Tribolet N: Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomas. J Neuroimmunol 29: 229–238, 1990

    Google Scholar 

  34. Pilkington GJ, Akinwunmi J, Ognjenovic N, Rogers JP: Differential binding of anti-CD44 on human gliomasin vitro. Neuroreport 4: 259–262, 1993

    Google Scholar 

  35. Li H, Hamou MF, de Tribolet N, Jaufeerally R, Hofmann M, Diserens AC, Van Meir EG: Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res 53: 5345–5349, 1993

    Google Scholar 

  36. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Gunthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124: 71–82, 1994

    Google Scholar 

  37. Harn HJ, Lee HS, Ho LI, Lee WH, Ding JH: Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines. Biochem Mol Biol Int 33: 743–749, 1994

    Google Scholar 

  38. Radotra B, McCormick D, Crockard A: CD44 plays a role in adhesive interactions between glioma cells and extracellular matrix components. Neuropathol Appl Neurobiol 20: 399–405, 1994

    Google Scholar 

  39. Kaaijk P, Troost D, Morsink F, Keehnen RMJ, Leenstra S, Bosch A, Pals ST: Expression of CD44 splice variants in human primary brain tumors. J NeuroOncol, this issue: 1995

  40. Eibl RH, Pietsch T, Moll J, Skroch-Angel P, Heidel K, von Ammon K, Wiestler OD, Ponta H, Kleihues P, Herrlich P: Expression of variant CD44 epitopes in human astrocytic brain tumors. J NeuroOncol, this issue: 1995

  41. Merzak A, Koochekpour S, Pilkington GJ: Cell surface gangliosides are involved in the control of human glioma cell invasionin vitro. Neurosci Lett 177: 44–46, 1994

    Google Scholar 

  42. Romeijn P, Lenthall R, Stavrou D, Melcher D, Ladyman H, Ritter MA: Identification of glioma-associated antigen MUC 2-63 as CD44. Br J Cancer 70: 799–803, 1994

    Google Scholar 

  43. Bergh J, Nilsson S, Liljedahl C, Maripuu E, Sivolapenko G, Epenetos A, Stavrou D: Radioimaging of human malignant gliomas using indium-labelled monoclonal antibodies. Nucl Med Comm 11: 437–444, 1990

    Google Scholar 

  44. Allen JC: Childhood brain tumors: current status of clinical trials in newly diagnosed and recurrent disease. [Review]. Pediatric Clinics of North America 32: 633–651, 1985

    Google Scholar 

  45. Favrot MC, Combaret V, Lasset C: CD44 a new prognostic marker for neuroblastoma [letter]. New Engl J Med 329: 1993

  46. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D: CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res 54: 4238–4242, 1994

    Google Scholar 

  47. Salmi M, Gron VK, Sointu P, Grenman R, Kalimo H, Jalkanen S: Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122: 431–442, 1993

    Google Scholar 

  48. Culty M, Shizari M, Thompson EW, Underhill CB: Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J Cellular Physiol 160: 275–286, 1994

    Google Scholar 

  49. Sherman L, Skroch-Angel P, Moll J, Schwechheimer K, Ponta H, Herrlich P, Hofmann M: Schwann cell tumors express characteristic patterns of CD44 splice variants. J NeuroOncol, this issue: 1995

  50. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, Gunthert U: CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51: 5292–5297, 1991

    Google Scholar 

  51. Heider KH, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, Pals ST: A human homologue of the rat metastasis-associated varaint of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120: 227–233, 1993

    Google Scholar 

  52. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177: 897–904, 1993

    Google Scholar 

  53. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754–4756, 1993

    Google Scholar 

  54. Vieth RG, Odom GL: Intracranial metastases and their neurosurgical treatment. J Neurosurg 23: 375–383, 1965

    Google Scholar 

  55. Nugent JL, Bunn PJ, Matthews MJ, Ihde DC, Cohen MH, Gazdar A, Minna JD: CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 44: 1885–1893, 1979

    Google Scholar 

  56. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54: 4539–4546, 1994

    Google Scholar 

  57. Reith A, Bjerkvig R, Rucklidge GJ: Laminin: a potential inhibitor of rat glioma cell invasionin vitro. Anticancer Res 14: 1071–1076, 1994

    Google Scholar 

  58. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR: Basement membrane complexes with biological activity. Biochemistry 25: 312–318, 1986

    Google Scholar 

  59. Giese A, Rief MD, Loo MA, Berens ME: Determinants of human astrocytoma migration. Cancer Res 54: 3897–3904, 1994

    Google Scholar 

  60. Velasquez WS: Primary central nervous system lymphoma. J Neuro Oncol 20: 177–185, 1994

    Google Scholar 

  61. Aho R, Ekfors T, Haltia M, Kalimo H: Pathogenesis of primary central nervous system lymphoma: invasion of malignant lymphoid cells into and within the brain parenchyme. Acta Neuropathol (Berl) 86: 71–76, 1993

    Google Scholar 

  62. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zoller M: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177: 443–455, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Tumour Biology and Genetics, Department of Neurosurgery, University Hospital (CHUV), Lausanne, Switzerland

    Gordon H. Baltuch, Nicolas de Tribolet & Erwin G. Van Meir

Authors
  1. Gordon H. Baltuch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicolas de Tribolet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erwin G. Van Meir
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baltuch, G.H., de Tribolet, N. & Van Meir, E.G. Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system. J Neuro-Oncol 26, 191–198 (1995). https://doi.org/10.1007/BF01052622

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01052622

Key words

Search

Navigation